reports
- ING Helpdesk
- Guy Sips
- Jacob Mekhael
- Livio Luyten
- Lynn Hautekeete
- Thomas Vranken
- Wim Lewi
- Jacob Mekhael
Hyloris FDA approval for Tranexamic Acid Intravenous Premix RTU
Hyloris announced that its partner Avenacy received FDA approval for its ANDA (generic NDA) of Tranexamic Acid Intravenous Premix Ready-to-Use (RTU), with launch planned for 2H25. This product, approved through the generic ANDA pathway, is non-core for the company, as Hyloris' main focus is on the more valuable reformulation and repurposing 505(b)(2) pathway. Sales of intravenous tranexamic acid reached $ 29.1m in the 12 months up to March 2025, and we estimate Hyloris could receive approx. $ 2m...
- ING Helpdesk
Benelux Morning Notes
Aedifica and Cofinimmo: Agreement reached to create Europe's leading Healthcare REIT. bpost: CMD press release; #Reshape 2029. D'Ieteren: Belgian new car registrations down 11.7% in May, VW down 13.5% Fugro: Meeting with CEO & IR; 2Q25 also has its challenges. UCB: Peer Moonlake held takeover talks with US Merck, FT reports
- Michiel Declercq
bpost Launches new 2024-2027 ambitions
Today, bpost launched its “Reshape 2029” strategy. This will be followed by a CMD in Brussels later today. Over the next years, bpost's intends to reposition itself as a logistics leader that also provides postal services. The transformation should result in group revenues exceeding € 5.0bn by 2027 (kbcse: € 4.8bn), with the adj. EBIT expected to progressively recover above € 275m (kbcse: € 208m). Growth is mainly expected to come from its 3PL business. While the outlook comes in comfortably abo...
- Guy Sips
- Jacob Mekhael
- Lynn Hautekeete
- Michiel Declercq
- Hilde Van Boxstael
- Kristof Samoy
- Wim Lewi
CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN...
CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER Antwerp, May 28, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) and Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) (“Golden Ocean”) are pleased to announce that they have signed an agreement and plan of merger (the “Merger Agreement”) for a stock-for-stock merger, as contemplated by the term sheet previously announced on 22 April 2025. The transaction is structur...
ForFarmers secures new credit facility
ForFarmers secures new credit facility Press release Lochem, 28 May 2025 ForFarmers secures new credit facility ForFarmers N.V. has signed a new credit facility for an amount of €150 million with an international banking syndicate. In addition, a €125 million working capital financing facility will become operational in mid-Q3 2025. To bridge the implementation period, a credit facility has been agreed with Rabobank. These facilities replace the previous financing agreement of €300 million. In addition, the activities of the joint ventures in Poland and Germany will, going forward, be...
ForFarmers sluit nieuwe kredietfaciliteit af
ForFarmers sluit nieuwe kredietfaciliteit af Persbericht Lochem, 28 mei 2025 ForFarmers sluit nieuwe kredietfaciliteit af ForFarmers N.V. heeft een nieuwe kredietfaciliteit ondertekend ter waarde van €150 miljoen met een internationaal bankensyndicaat. Tevens zal medio Q3 2025 een werkkapitaal financiering van €125 miljoen operationeel zijn. Voor de overbrugging van de periode van implementatie van deze werkkapitaal financiering is een kredietfaciliteit met Rabobank afgesloten. Deze aanpak vervangt de vorige financieringsovereenkomst die €300 miljoen bedroeg. Daarnaast zijn de activiteit...
CMB.TECH results general meetings
CMB.TECH results general meetings Antwerp, May 22, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) announces that today the General Meeting of Shareholders has approved the annual accounts for the year ended 31 December 2024. All other resolutions proposed by CMB.TECH’s Supervisory Board have also been approved. Reappointment of Supervisory Board members Shareholders voted to reappoint independent director Julie De Nul as Supervisory Board member. Furthermore, the General Shareholder Meeting approved the Resignation of Mr. Patri...
- Jacob Mekhael
Hyloris Deal with AFT for XTRAZA in selected APAC regions and Canada
Hyloris announced an exclusive licensing agreement with AFT Pharmaceuticals for XTRAZA (tranexamic acid oral rinse) in Canada, Australia, New Zealand, Singapore and Hong Kong. Under the terms of the agreement Hyloris will receive up to 50% of the gross profits generated. This deal with AFT follows a previously announced agreement for the UK with Colonis Pharma. A phase 3 trial for XTRAZA is ongoing in the US and EU, with data expected by YE25, and we note that a deal for XTRAZA in the larger US...
- Hilde Van Boxstael
- Jacob Mekhael
- Livio Luyten
- Michiel Declercq
- Wim Hoste
- Wim Lewi
- Guy Sips
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Thomas Vranken
CMB.TECH announces Q1 2025 results
CMB.TECH announces Q1 2025 results CMB.TECH ANNOUNCES Q1 2025 RESULTS 1 BILLION USD CONTRACT BACKLOG ADDED ANTWERP, Belgium, 21 May 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) reported its non-audited financial results today for the first quarter ended 31 March 2025. HIGHLIGHTS Financial highlights: Profit of USD 40.4 million in Q1 2025CMB.TECH increases its contract backlog by USD 921 million (to USD 2.94 billion) Corporate highlights: CMB.TECH buys Hemen stake in Golden OceanTerm sheet signed for a stock-for-stock merger transac...
Update on and end of share buy-back programme ForFarmers
Update on and end of share buy-back programme ForFarmers Lochem, 20 May 2025 Update on and end of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 37,881 shares on 19 May 2025. The shares were repurchased at an average price of €4.36 per share, for a total amount of €165,260. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 17 April 2025. The authorisation concerns the buy-back of shares for ForFarmers to fulfil its obligations arising from (depositary receipts for) share...
Voortgang en einde inkoopprogramma eigen aandelen ForFarmers
Voortgang en einde inkoopprogramma eigen aandelen ForFarmers Lochem, 20 mei 2025 Voortgang en einde inkoopprogramma eigen aandelen ForFarmers ForFarmers N.V. (ForFarmers) heeft 37.881 aandelen ingekocht op 19 mei 2025. De aandelen zijn ingekocht met een gemiddelde prijs van €4,36 per aandeel, voor een totaalbedrag van €165.260. Deze inkopen zijn gedaan in overeenstemming met de machtiging verleend door de Algemene Vergadering van Aandeelhouders van ForFarmers op 17 april 2025. De machtiging betreft de inkoop van eigen aandelen zodat ForFarmers haar verplichtingen kan nakomen die voortv...
Update of share buy-back programme ForFarmers
Update of share buy-back programme ForFarmers Lochem, 19 May 2025 Update of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 212,721 shares in the period from 12 May 2025 through 16 May 2025. The shares were repurchased at an average price of €4.20 per share, for a total amount of €892,460. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 17 April 2025. The authorisation concerns the buy-back of shares for ForFarmers to fulfil its obligations arising from (depositary rece...
Voortgang inkoopprogramma eigen aandelen ForFarmers
Voortgang inkoopprogramma eigen aandelen ForFarmers Lochem, 19 mei 2025 Voortgang inkoopprogramma eigen aandelen ForFarmers ForFarmers N.V. (ForFarmers) heeft 212.721 aandelen ingekocht in de periode van 12 mei 2025 tot en met 16 mei 2025. De aandelen zijn ingekocht met een gemiddelde prijs van €4,20 per aandeel, voor een totaalbedrag van €892.460. Deze inkopen zijn gedaan in overeenstemming met de machtiging verleend door de Algemene Vergadering van Aandeelhouders van ForFarmers op 17 april 2025. De machtiging betreft de inkoop van eigen aandelen zodat ForFarmers haar verplichtingen kan ...
- Marc Zwartsenburg
- CEFA
bpost/Surprisingly positive Last Mile; upgrade coming?/HOLD
We keep our HOLD rating, but we increase our target price from €1.55 to €1.75. bpost reported a strong 1Q25 with a 22% beat vs company compiled consensus. Whereas BeNe Last Mile disappointed in the previous quarter, it now surprised strongly on the upside despite the impact from the strikes. bpost does not see an impact from the tariff wars and it might be less of an issue than initially expected. Radial US is still in a tough spot but with an improving pipeline while Staci seemed on track, alth...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.